undefined cover
undefined cover
Caution with tumor marker testing; Career development for residents cover
Caution with tumor marker testing; Career development for residents cover
PATH News Network Daily Edition

Caution with tumor marker testing; Career development for residents

Caution with tumor marker testing; Career development for residents

02min |23/07/2025
Play
undefined cover
undefined cover
Caution with tumor marker testing; Career development for residents cover
Caution with tumor marker testing; Career development for residents cover
PATH News Network Daily Edition

Caution with tumor marker testing; Career development for residents

Caution with tumor marker testing; Career development for residents

02min |23/07/2025
Play

Transcription

  • Speaker #0

    Be careful with that body fluid tumor marker. Plus, a CME-accredited workshop at CAP25 can help you turn evaluations into growth opportunities. Coming up on the Path News Network. This is the PATH News Network Daily Edition, powered by the College of American Pathologists. I'm Dafna Farkas. It's Wednesday, July 23rd. Here are the latest headlines. Body-fluid tumor marker tests must be treated with caution. That's advice from Dr. Jonathan Genzen, writing in the June edition of CAP TODAY. Dr. Genzen is chair of the CAP Clinical Chemistry Committee. He notes that without FDA clearance, labs are fully responsible for validating every step, especially pretreatments which can skew results. The takeaway? These tests can support clinical decisions, but only after validation has excluded the possibility of matrix interference. Read the full article using the link in the show notes. CAP25 is coming up soon. Attendees can learn how to strengthen professional relationships and personal development through a hands-on, CME-accredited workshop. Using real-world scenarios, the session will cover goal setting, how to prepare for performance evaluations and feedback, and strategies for turning these conversations into growth opportunities. Register today through the link in the show notes to get $200 off an all-access pass with code CME25200. Are you a pathology resident looking for a head start in your career? You'll gain insights into career development, networking, and professional community building at the CAP Residence Forum Meeting on Saturday, September 13th in Orlando. Coinciding with CAP25, this free full-day meeting offers opportunities to connect with peers and engage with leaders in the field. Programming is designed to support residents as they transition into the next stage of their careers. There's a link in the show notes. And finally, save money for your organization by signing up now for the CAP group membership. This year, groups can save 20 to 30 percent. The larger your group, the more you save. Get additional details and start the registration process using the link in the show notes. That's all for today. Be sure to watch your email inbox for more news like this in the CAP's advocacy newsletter every Tuesday and our weekly edition newsletter every Thursday. Listen here again tomorrow at 5 a.m. Eastern time for another episode of The Daily Edition. Also, get the news delivered to your podcast app each morning by clicking the plus sign on this player. I'm Dafna Farkas. Have a great day.

Transcription

  • Speaker #0

    Be careful with that body fluid tumor marker. Plus, a CME-accredited workshop at CAP25 can help you turn evaluations into growth opportunities. Coming up on the Path News Network. This is the PATH News Network Daily Edition, powered by the College of American Pathologists. I'm Dafna Farkas. It's Wednesday, July 23rd. Here are the latest headlines. Body-fluid tumor marker tests must be treated with caution. That's advice from Dr. Jonathan Genzen, writing in the June edition of CAP TODAY. Dr. Genzen is chair of the CAP Clinical Chemistry Committee. He notes that without FDA clearance, labs are fully responsible for validating every step, especially pretreatments which can skew results. The takeaway? These tests can support clinical decisions, but only after validation has excluded the possibility of matrix interference. Read the full article using the link in the show notes. CAP25 is coming up soon. Attendees can learn how to strengthen professional relationships and personal development through a hands-on, CME-accredited workshop. Using real-world scenarios, the session will cover goal setting, how to prepare for performance evaluations and feedback, and strategies for turning these conversations into growth opportunities. Register today through the link in the show notes to get $200 off an all-access pass with code CME25200. Are you a pathology resident looking for a head start in your career? You'll gain insights into career development, networking, and professional community building at the CAP Residence Forum Meeting on Saturday, September 13th in Orlando. Coinciding with CAP25, this free full-day meeting offers opportunities to connect with peers and engage with leaders in the field. Programming is designed to support residents as they transition into the next stage of their careers. There's a link in the show notes. And finally, save money for your organization by signing up now for the CAP group membership. This year, groups can save 20 to 30 percent. The larger your group, the more you save. Get additional details and start the registration process using the link in the show notes. That's all for today. Be sure to watch your email inbox for more news like this in the CAP's advocacy newsletter every Tuesday and our weekly edition newsletter every Thursday. Listen here again tomorrow at 5 a.m. Eastern time for another episode of The Daily Edition. Also, get the news delivered to your podcast app each morning by clicking the plus sign on this player. I'm Dafna Farkas. Have a great day.

Share

Embed

You may also like

Transcription

  • Speaker #0

    Be careful with that body fluid tumor marker. Plus, a CME-accredited workshop at CAP25 can help you turn evaluations into growth opportunities. Coming up on the Path News Network. This is the PATH News Network Daily Edition, powered by the College of American Pathologists. I'm Dafna Farkas. It's Wednesday, July 23rd. Here are the latest headlines. Body-fluid tumor marker tests must be treated with caution. That's advice from Dr. Jonathan Genzen, writing in the June edition of CAP TODAY. Dr. Genzen is chair of the CAP Clinical Chemistry Committee. He notes that without FDA clearance, labs are fully responsible for validating every step, especially pretreatments which can skew results. The takeaway? These tests can support clinical decisions, but only after validation has excluded the possibility of matrix interference. Read the full article using the link in the show notes. CAP25 is coming up soon. Attendees can learn how to strengthen professional relationships and personal development through a hands-on, CME-accredited workshop. Using real-world scenarios, the session will cover goal setting, how to prepare for performance evaluations and feedback, and strategies for turning these conversations into growth opportunities. Register today through the link in the show notes to get $200 off an all-access pass with code CME25200. Are you a pathology resident looking for a head start in your career? You'll gain insights into career development, networking, and professional community building at the CAP Residence Forum Meeting on Saturday, September 13th in Orlando. Coinciding with CAP25, this free full-day meeting offers opportunities to connect with peers and engage with leaders in the field. Programming is designed to support residents as they transition into the next stage of their careers. There's a link in the show notes. And finally, save money for your organization by signing up now for the CAP group membership. This year, groups can save 20 to 30 percent. The larger your group, the more you save. Get additional details and start the registration process using the link in the show notes. That's all for today. Be sure to watch your email inbox for more news like this in the CAP's advocacy newsletter every Tuesday and our weekly edition newsletter every Thursday. Listen here again tomorrow at 5 a.m. Eastern time for another episode of The Daily Edition. Also, get the news delivered to your podcast app each morning by clicking the plus sign on this player. I'm Dafna Farkas. Have a great day.

Transcription

  • Speaker #0

    Be careful with that body fluid tumor marker. Plus, a CME-accredited workshop at CAP25 can help you turn evaluations into growth opportunities. Coming up on the Path News Network. This is the PATH News Network Daily Edition, powered by the College of American Pathologists. I'm Dafna Farkas. It's Wednesday, July 23rd. Here are the latest headlines. Body-fluid tumor marker tests must be treated with caution. That's advice from Dr. Jonathan Genzen, writing in the June edition of CAP TODAY. Dr. Genzen is chair of the CAP Clinical Chemistry Committee. He notes that without FDA clearance, labs are fully responsible for validating every step, especially pretreatments which can skew results. The takeaway? These tests can support clinical decisions, but only after validation has excluded the possibility of matrix interference. Read the full article using the link in the show notes. CAP25 is coming up soon. Attendees can learn how to strengthen professional relationships and personal development through a hands-on, CME-accredited workshop. Using real-world scenarios, the session will cover goal setting, how to prepare for performance evaluations and feedback, and strategies for turning these conversations into growth opportunities. Register today through the link in the show notes to get $200 off an all-access pass with code CME25200. Are you a pathology resident looking for a head start in your career? You'll gain insights into career development, networking, and professional community building at the CAP Residence Forum Meeting on Saturday, September 13th in Orlando. Coinciding with CAP25, this free full-day meeting offers opportunities to connect with peers and engage with leaders in the field. Programming is designed to support residents as they transition into the next stage of their careers. There's a link in the show notes. And finally, save money for your organization by signing up now for the CAP group membership. This year, groups can save 20 to 30 percent. The larger your group, the more you save. Get additional details and start the registration process using the link in the show notes. That's all for today. Be sure to watch your email inbox for more news like this in the CAP's advocacy newsletter every Tuesday and our weekly edition newsletter every Thursday. Listen here again tomorrow at 5 a.m. Eastern time for another episode of The Daily Edition. Also, get the news delivered to your podcast app each morning by clicking the plus sign on this player. I'm Dafna Farkas. Have a great day.

Share

Embed

You may also like

undefined cover
undefined cover